Product Images Amlodipine Besylate 5 Mg

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Amlodipine Besylate 5 Mg NDC 69584-022 by Oxford Pharmaceuticals, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

10mg Label

10mg Label

This is a medication description for a tablet of Amlodipine Besylate. The medication is manufactured by Oot Pharmaceutical located in Birmingham, Alabama. The medication is prescribed by a pharmacist and must be dispensed with a patient information sheet. The last dosage revision for this medication was on January 27th, 2021. The medication should be taken orally. The text also includes various codes and contact information for the manufacturer.*

2.5mg Label

2.5mg Label

This is a description of a medication called Amlodipine Besylate. It comes in tablet form and is manufactured by a company called Semmgan Advamediztt. The medication is only available with a prescription from a pharmacist and comes in bottles containing 1000 tablets. The packaging contains a serialization area and instructions on how to print a patient information sheet by visiting a website called pswwadions mcomimed-gues. The manufacturer appears to be Oxford Pharmaceuticals LLC.*

5mg Label

5mg Label

This appears to be a medication label for Amlodipine Besylate tablets, with the National Drug Code (NDC) 69584-022. The label includes dosage information and instructions for pharmacists to dispense the medication with a patient information sheet, which can be printed from a website provided. The label is associated with Oxford Pharmaceuticals, LLC.*

figure-1 - figure1

figure-1 - figure1

This appears to be a statistical output of a survival analysis involving a treatment (Amlodipine) and a control group (Placebo). The output includes the Event Rate, P-value, Hazard Ratio, and Confidence Interval. Additionally, there is a graph that charts time (in months) and the number at risk. This output is likely part of a larger analysis that aims to compare the effectiveness of Amlodipine versus the Placebo.*

figure-2 - figure2

figure-2 - figure2

This is a table showing the demographics and baseline characteristics of patients in a study. It includes information on age, gender, baseline blood pressure, vessel disease, vessel stenosis, and types of treatments received. The number of participants is also noted for each category. There is a section at the bottom with an unclear title and two values, "Favors Amlodipine" and "Favors Placebo," with a "Hazard Ratio" listed but no explanation is given for these values.*

structure - structure

structure - structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.